Medtronic plc has announced the groundbreaking of a new campus in Lafayette, Colorado. The new campus will unite 1000 employees from … continue reading “Medtronic Breaks Ground on New Innovation Center”
Companies
Pain Relief Boost with Spinal Cord Stimulator Approval
Pain relief using implantable neurostimulation has come on a lot in recent times. For evidence, try searching our pages. Now … continue reading “Pain Relief Boost with Spinal Cord Stimulator Approval”
U.S. FDA Approves Pipeline™ Flex Embolization Device with Shield Technology™
Medtronic plc has received U.S. FDA approval for Pipeline™ Flex Embolization Device with Shield Technology™. Background An estimated 500,000 people throughout the … continue reading “U.S. FDA Approves Pipeline™ Flex Embolization Device with Shield Technology™”
FDA Approves Expanded Labeling of Medtronic MRI Leads
Medtronic plc says it has received approval from the U.S. FDA for expanded MRI labeling of its InterStim™ II and InterStim™ … continue reading “FDA Approves Expanded Labeling of Medtronic MRI Leads”
FDA Clearances Enhance Mazor™ Robotic Guidance System
The U.S. FDA has cleared the use of navigated interbody and Midas Rex™ high speed drills with the Mazor™ Robotic Guidance System earlier than originally anticipated
FDA OKs ReCor Paradise™ Ultrasound Renal Denervation
ReCor Medical’s Paradise™ Ultrasound Renal Denervation System has received Breakthrough Device Designation from the U.S. FDA for the treatment of patients with uncontrolled hypertension who are inadequately responsive to anti-hypertensive medications.
Carpediem™ First Cardio-Renal Pediatric Dialysis Launch
Medtronic plc has announced the U.S. commercial launch of the Carpediem™ Cardio-Renal Pediatric Dialysis Emergency Machine, the first and only … continue reading “Carpediem™ First Cardio-Renal Pediatric Dialysis Launch”
U.S. Launch for Boston Scientific SpaceOAR Vue™ Hydrogel
Next-generation Hydrogel spacer offers enhanced visibility via CT Scan to optimize treatment planning for patients undergoing radiation for prostate cancer. … continue reading “U.S. Launch for Boston Scientific SpaceOAR Vue™ Hydrogel”
Medtronic’s ENT Portfolio Grows with FDA Clearance of NIM Vital and Acquisition of Ai Biomed
Medtronic plc, has received U.S. FDA 510(k) clearance of the NIM Vital™ nerve monitoring system, which enables physicians to identify, … continue reading “Medtronic’s ENT Portfolio Grows with FDA Clearance of NIM Vital and Acquisition of Ai Biomed”
Medtronic DTM™ Spinal Cord Stimulation Therapy Outperforms Conventional SCS Therapy for Back Pain Relief at 12 Months
Statistically significant 12-month results from a large, multicenter randomized controlled trial confirm 84% Back Pain Responder Rate and 69% Profound … continue reading “Medtronic DTM™ Spinal Cord Stimulation Therapy Outperforms Conventional SCS Therapy for Back Pain Relief at 12 Months”
First Patients in Europe Treated with Biosense Webster VARIPULSE® AF Catheter
Johnson & Johnson Medical Devices Companies’ Biosense Webster, Inc., says the first patients have been enrolled and treated in its … continue reading “First Patients in Europe Treated with Biosense Webster VARIPULSE® AF Catheter”
FDA Approval for Biosense Webster THERMOCOOL SMARTTOUCH® SF Ablation Catheter for Persistent Atrial Fibrillation
Johnson & Johnson Medical Devices Companies have announced the U.S. FDA approval of Biosense Webster, Inc.’s THERMOCOOL SMARTTOUCH® SF Ablation … continue reading “FDA Approval for Biosense Webster THERMOCOOL SMARTTOUCH® SF Ablation Catheter for Persistent Atrial Fibrillation”
Medtronic Launches Adaptix™ Interbody System, First Navigated Titanium Cage with Titan nanoLOCK™ Surface Technology
Medtronic plc, has chosen the North American Spine Society (NASS) annual meeting at which to announce the U.S. launch of … continue reading “Medtronic Launches Adaptix™ Interbody System, First Navigated Titanium Cage with Titan nanoLOCK™ Surface Technology”
Two New FDA-Approved Bladder and Bowel Control Therapies
Medtronic plc, has received approval from the US FDA for its InterStim™ Micro neurostimulator and InterStim™ SureScan™ MRI leads. Background … continue reading “Two New FDA-Approved Bladder and Bowel Control Therapies”
Rezūm™ Water Vapor BPH Therapy Effective After Five Years
New clinical study results say the Rezūm System provided significant, sustained improvement of lower urinary tract symptoms (LUTS) and quality of … continue reading “Rezūm™ Water Vapor BPH Therapy Effective After Five Years”
CE Mark for “World First” Single-Use Duodenoscope, EXALT Model D
Boston Scientific Corporation has gained the CE Mark and initiated a limited market release of the EXALT™ Model D Single-Use (disposable) … continue reading “CE Mark for “World First” Single-Use Duodenoscope, EXALT Model D”